Refine
Document Type
- Journal article (11)
- Book chapter (5)
- Book (1)
Is part of the Bibliography
- yes (17)
Institute
- Life Sciences (17)
- ESB Business School (1)
Publisher
- Springer (5)
- Elsevier (4)
- Wiley (4)
- Marken-Institut München (1)
- National Library of Medicine (1)
- Ochre Media (1)
- Taylor & Francis (1)
Comparative analysis of the R&D efficiency of 14 leading pharmaceutical companies for the years 1999–2018 shows that there is a close positive correlation between R&D spending and the two investigated R&D output parameters, approved NMEs and the cumulative impact factor of their publications. In other words, higher R&D investments (input) were associated with higher R&D output. Second, our analyses indicate that there are "economies of scale" (size) in pharmaceutical R&D.